Disseminated Fusarium Infections in Acute Lymphoblastic Leukemia

1. Nelson PE, Dignani MC, Anaissie EJ. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev. 1994;7(4):479-504.10.1128/CMR.7.4.479Open DOISearch in Google Scholar

2. Galimberti R, Torre AC, Baztán MC, Rodriguez-Chiappetta F. Emerging systemic fungal infections. Clin Dermatol. 2012;30(6):633-50.2306815110.1016/j.clindermatol.2012.01.011Search in Google Scholar

3. Nucci M, Anaissie E. Fusarium infections in immunocompromised pat ients. Cl in Microbiol Rev. 2007;20(4):695-704.10.1128/CMR.00014-07Open DOISearch in Google Scholar

4. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev. 1996;9(4):499-511.10.1128/CMR.9.4.499Open DOISearch in Google Scholar

5. Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect. 2004;10 Suppl 1:67-75.1474880310.1111/j.1470-9465.2004.00845.xSearch in Google Scholar

6. Nucci F, Nouér SA, Capone D, Anaissie E, Nucci M. Fusariosis. Semin Respir Crit Care Med. 2015; 36(5):706-14.10.1055/s-0035-1562897Search in Google Scholar

7. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):e56-93.10.1093/cid/cir073Open DOISearch in Google Scholar